Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Earnings, healthcare give Wall St sixth straight gain

Tue, 22nd Apr 2014 21:26

* S&P 500, Nasdaq on six-day winning streak

* Netflix up after results; Facebook gains on upgrade

* Allergan soars as Ackman and Valeant bid for company

* Dow up 0.4 pct; S&P 500 up 0.4 pct; Nasdaq up 1 pct (Adds Gilead earnings, updates volume)

By Chuck Mikolajczak

NEW YORK, April 22 (Reuters) - U.S. stocks rose on Tuesdayas a host of solid earnings reports, along with strength in thehealthcare sector, helped lift the S&P 500 and Nasdaq to theirsixth straight advance.

Netflix Inc surged 7 percent to $372.90 a day afterreporting strong subscriber growth, a sign the trading favoritestill had room to grow despite recent valuation concerns. Withthe day's gain, the stock moved to the plus side for the yearafter a 21 percent drop in March.

The S&P healthcare index, up 1 percent, was thebest performer of the 10 major S&P sectors. Allergan Inc jumped 15.2 percent to $163.65 a day after activist investorWilliam Ackman teamed up with Canadian drugmaker ValeantPharmaceuticals International Inc to bid for thecompany. U.S.-listed Valeant shares gained 7.5 percent to$135.41.

A deal between Novartis and GlaxoSmithKline, in which the two traded over $20 billion worth ofassets in an effort to cope with healthcare spending cuts andgeneric competition, also bolstered the healthcare sector.U.S.-listed shares of Novartis gained 1.3 percent to$86.56, while Glaxo rose 4.1 percent to $55.30.

Better-than-expected earnings have lifted stocks recently,though companies have largely been exceeding reduced forecasts.Profits are seen rising 1.1 percent this quarter, down from the6.5 percent growth rate estimated at the start of the year.

"What was baked into the market, in spite of a market nearan all-time high, was a sloppy earnings season," said MikeSerio, regional chief investment officer of Wells Fargo PrivateBank in Denver.

"We've had some really good beats at this point, we've had acouple of good announcements today, you throw on the M&Aactivity in the drug sector, at least in the short term,everybody looks pretty excited about this market."

Dow components Travelers Cos Inc and UnitedTechnologies Corp both beat expectations, and UnitedTech raised the low end of its full-year profit outlook. Sharesof Travelers rose 0.6 percent to $86.89 while United Tech added0.8 percent to end at $119.19.

McDonald's Corp reported earnings that fellalongside a drop in U.S. same-store sales, and its stock slipped0.4 percent to $99.32.

With 20 percent of the S&P 500 having reported resultsthrough Tuesday morning, 63 percent have topped earningsexpectations, according to Thomson Reuters data, matching thelong-term average. On the revenue side, 51 percent have exceededforecasts, below the 61 percent long-term average.

The Dow Jones industrial average rose 65.12 points or0.40 percent, to end at 16,514.37. The S&P 500 gained7.66 points or 0.41 percent, to 1,879.55. The Nasdaq Composite added 39.912 points or 0.97 percent, to 4,161.458.

After the close, Gilead Sciences Inc advanced 1.1percent to $73.65 after the drugmaker said its new $1,000hepatitis C pill generated quarterly sales of $2.27 billion,helping the company's quarterly net profit nearly triple.

In another positive sign for equities, the Dow JonesTransportation Average, up 0.6 percent, closed at itsfirst record high since April 2. The index got a boost fromairlines such as United Continental Holdings, up 4.6percent, and Alaska Air Group Inc, up 1.3 percent, whichrose on a 2 percent drop in oil prices.

Facebook Inc shares rose 2.9 percent to $63.03,helping to lift the Nasdaq 100 and the S&P 500. CreditSuisse upgraded the social networking company's stock to"outperform" on higher expectations for its long-term averagerevenue per user.

Volume was light, with about 5.88 billion shares traded onU.S. exchanges, below the 6.7 billion average so far this month,according to data from BATS Global Markets.

Advancing stocks outnumbered declining ones on the NYSE by2,227 to 811, while on the Nasdaq, advancers beat decliners1,900 to 727. (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski andJan Paschal)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.